RACHEL STRAUS: Open Payments
NPI 1326621095 · FLUSHING, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,283 in 62 payments from 12 companies in 2025. Trend: 2023 $246 · 2024 $378 · 2025 $1,283
Food & beverage: $1,211Education: $72
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 19 | $399 |
| ABBVIE INC. | 7 | $262 |
| Arcutis Biotherapeutics, Inc. | 21 | $214 |
| Novartis Pharmaceuticals Corporation | 5 | $105 |
| Janssen Biotech, Inc. | 1 | $72 |
| Botanix SB Inc | 2 | $45 |
| Regeneron Healthcare Solutions, Inc. | 2 | $38 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $34 |
| UCB, Inc. | 1 | $34 |
| GENZYME CORPORATION | 1 | $29 |
Products named: OPZELURA, SKYRIZI, Zoryve, TREMFYA, COSENTYX, DUPIXENT, SOFDRA, ILUMYA.
Industry payments across NY — which companies pay providers there.
